Cargando…
Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study
INTRODUCTION: Osteoporosis is one of the important bone abnormalities in chronic kidney disease-mineral and bone disorder (CKD-MBD) and still lacks a sensitive biomarker to diagnose. Fibroblast growth factor 21 (FGF21) can stimulate bone loss in patients with diabetes and increase in CKD patients. I...
Autores principales: | Zhu, Lili, Li, Min, Zha, Qianqian, Yang, Min, Yu, Jirong, Pan, Mingming, Yin, Qing, Jiang, Liqiong, Xia, Meixia, Liu, Bi-Cheng, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135985/ https://www.ncbi.nlm.nih.gov/pubmed/34011291 http://dx.doi.org/10.1186/s12882-021-02393-z |
Ejemplares similares
-
Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011) -
Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions
por: Min, Xiaoshan, et al.
Publicado: (2018) -
Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes
por: Tan, Bee K., et al.
Publicado: (2013) -
Exercise Increases Serum Fibroblast Growth Factor 21 (FGF21) Levels
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2012) -
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
por: Fisher, ffolliott M., et al.
Publicado: (2010)